She was fifteen when she watched her sister come home from another failed round of IVF, after another long journey to a city that had the treatment their hometown did not. She decided, then, to become the doctor who closed that gap. Two decades on, she runs the chain that did, and she went to Stanford EMBA to do it better, without ever taking a GMAT.

Dr. Gauri Agarwal grew up middle-class in Kanpur, in a family where her father’s great hope was that she would become a doctor. She did become one, though not quite for the reason he imagined. The reason was her sister. Gauri was still a teenager when she watched her sister go through five failed cycles of IVF, travelling all the way to Mumbai each time because a city like Kanpur simply did not offer the treatment. Her sister finally conceived when Gauri was in Class 11, and then came through a serious complication of the process itself. Gauri was fifteen when she decided what she would do with her life, and the decision was unusually precise. She would study embryology and reproductive medicine, and she would spend her career on the gaps that had caused her sister so much pain, including the cruel and ordinary one of simply living too far from good care.

She kept the promise with remarkable exactness. After her MBBS in Pune and her DNB in Coimbatore, she went and trained in embryology and reproductive medicine at the National University of Singapore and at the University of Ghent in Belgium, two of the better places in the world to learn it. She had, by then, married into a family of doctors, the Aroras, whose hospital group in Ghaziabad would have made the easy path very easy indeed. She could have opened her first fertility centre inside the family hospital, under its name and its protection, and almost no one would have blinked.

The harder road, on purpose

She chose not to. Determined to understand the market on her own terms, and unwilling to take the family’s support for granted, she started small and she started outside, running health camps in the rural areas around Dadri and Loni where IVF was not merely unavailable but more or less unheard of. In 2015 she opened the first centre of Seeds of Innocence in Delhi’s Malviya Nagar, bootstrapped, funded by her own early cases, with the profits ploughed straight back in. What she was building was exactly the thing her sister had needed and not had, which was fertility care that did not demand a desperate journey to one of a handful of big cities.

The years that followed were not gentle, and she has been candid about that. She opened a centre in Ghaziabad in 2017 as the mother of a small child, while people around her wondered aloud whether a woman could really run an independent venture of this kind. She was pregnant with her second child as the practice grew, starting her days at five in the morning because that was the only hour the best embryologist in Delhi could give her. On the day she delivered that child, she handled procedures in the morning, went from there to the labour room, and was back at work within three days. She has spoken, since, about the postpartum depression she came through in that period, and about how the gratitude of the families she had helped, together with her husband’s steadiness, carried her through it. It is not a tidy founder’s story. It is a truer one.

Turning grief into a genetics lab

One early case changed the shape of the whole enterprise. In 2015, a pregnancy she was caring for was found, at thirteen weeks, to carry a severe condition, and the patient was a woman who had taken a loan to afford the IVF in the first place. The sheer unfairness of it lodged in her. It pushed her to do something no IVF clinic in India had yet done, which was to bring advanced reproductive genetics in-house rather than shipping samples abroad to Belgium and Spain and waiting on the result. That decision grew into Genestrings, a genetics laboratory now recognised by the Government of India and designated a centre of excellence for autism research, building a gene panel specific to the Indian population. Her clinical results climbed accordingly, to success rates near eighty percent against an industry norm closer to forty, helped by the genetic screening and other techniques she introduced ahead of almost everyone else in the country.

True to the original promise, she pushed the model outward rather than upward, into the smaller cities and towns that fertility medicine had always ignored, connecting rural outpatient centres to urban hubs and adopting an entire village near Mathura for its primary care. To take on the cost, which is brutal in a country where a single IVF cycle can run to several months of an ordinary family’s income and is not covered by most insurance, she introduced interest-free monthly instalments, a first of its kind in Indian fertility care. Her work drew the government’s notice, including a national mentorship role in mother and child health and a national quality award, though she is quick to say that it is the impact, and not the awards, that she actually counts.

Stanford EMBA, in the worst possible year

It was at this point, already running a fast-growing chain, a genetics company, and a cancer unit, that she set out to gain the one thing her medical training had never given her, which was the senior business education to scale all of it without losing its soul. Like the Kellogg route her husband had taken, the Stanford EMBA does not ask for a GMAT; it admits proven senior leaders on the strength of what they have actually built. She got in, for the 2020 cohort. The timing could hardly have been crueller. The pandemic arrived, IVF was declared a non-essential service, and her patients, many of them older women losing precious time with each passing month, were left stranded. Her response tells you who she is. She kept treatment going by sending nurses and injections to patients’ homes, protected her surrogates, and brought her whole organisation through without major salary cuts or layoffs. Then she turned her genetics labs toward COVID testing, earned national certification, and helped set up India’s first full-fledged test-on-arrival laboratory at an airport. She arrived at Stanford as a leader who had just proven, under the worst conditions imaginable, the precise kind of leadership the programme exists to develop.

Today Seeds of Innocence has grown past twenty-five centres across India, Genestrings has become a serious diagnostics business in its own right, and the gap that a fifteen-year-old once noticed between her sister and the care she needed is, in a great many towns, simply no longer there.

Our role was the smallest part of this. When Gauri came to us, the challenge was never substance, of which she had an extraordinary amount, but compression and shape, taking a sprawling decade of clinical, social, and commercial impact and finding the single human thread that ran through all of it, the one that led back to her sister. We helped her tell that story so that Stanford could see it whole. Everything in the story, she had already lived.

What you can take from Gauri’s story to Stanford EMBA

A teenager in Kanpur once decided that her sister should not have had to travel so far, or hurt so much, for the chance to have a child. The whole of Dr. Gauri Agarwal’s career has been the keeping of that promise, and Stanford was simply one more place she went in order to keep it better.